Martin A. Lehr, Chief Executive Officer at Context Therapeutics Inc. (CNTX), bought 5,040 shares at $0.97 ($5K) on 2023-02-06, disclosed to the SEC on 2023-02-06.
Scheduled purchase ($5k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CNTX | BUY | 2023-02-13 | $5K | — | Filing → |
| CNTX | BUY | 2023-01-30 | $5K | — | Filing → |
| CNTX | BUY | 2023-01-23 | $5K | — | Filing → |